Nova Eye Medical
New data shows iTrack efficacy as both standalone and combined MIGS procedure
Nova Eye Medical has published two-year data for its iTrack ab-interno canaloplasty procedure, which it says showed an average reduction ...
Five-year post-LEAD trial garners positive results for 2RT
Nova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its ...
Making a stand for MBGS under Medicare
Advances in glaucoma stent technology far outstripped the Medicare schedule early on, creating a disconnect that had far-reaching consequences. As ...
New iTrack trial comparing efficacy and safety ab-interno canaloplasty
Nova Eye Medical has announced eight surgery centres across the US have commenced a prospective, randomised clinical trial to assess ...
Public MIGS funding a step closer for iTrack in Australia
Nova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally ...
Aussie firm pushes for Medicare wording change to standalone MIGS
Nova Eye Medical is seeking a modification to the existing minimally invasive glaucoma surgery (MIGS) Medicare item number that only ...
Aussie firm reveals next-gen MIGS device in pipeline
Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. ...